Cryoport, Inc. — Director's Dealing 2023

Mar 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2023-03-09

Reporting Person: Sawicki Mark W (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-09	Common Stock	M	2667	—	Acquired	64508	Direct
2023-03-13	Common Stock	S	1476	$20.14	Disposed	63032	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-09	Restricted Stock Rights	$	M	2667	Disposed		Common Stock (2667)	Direct

Footnotes

F1: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F2: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

F3: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023.